Thiel Capital is a company that specializes in investment management services.
Business Model:
Revenue: $16M
Employees: 51-200
Address: 1 Letterman Dr Ste 400
City: San Francisco
State: CA
Zip: 94129
Country: US
Thiel Capital is an investment firm founded by Peter Thiel. Located in the Presidio of San Francisco, Thiel Capital provides strategic and operational support for Peter’s many investment initiatives and entrepreneurial endeavors. Related organizations include Clarium, Founders Fund, Mithril, Valar Ventures, and The Thiel Foundation.
Contact Phone:
+14154411460
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2021 | ATAI Life Sciences | Series D | 0 |
11/2020 | ATAI Life Sciences | Series C | 0 |
8/2022 | 28 by Evie | Seed Round | 0 |
2/2020 | EnClear Therapies | Series A | 0 |
3/2019 | EnClear Therapies | Seed Round | 2M |
2/2022 | Regent | Equity | 18M |
7/2018 | Compass Therapeutics, Inc. | Series A | 0 |
10/2022 | Alloy Therapeutics | Series D | 42M |
9/2022 | Vienna Hypertext | Seed Round | - |
4/2020 | ATAI Life Sciences | Convertible Note | 25M |
5/2021 | Bullish Global | Venture Round | 300M |
8/2018 | Spark Neuro | Series A | 13.5M |
12/2019 | Chemomab | Series C | 20M |
7/2020 | Compass Therapeutics, Inc. | Venture Round | 0 |
11/2017 | Immunochina | Series B | 7.5M |
7/2017 | Compass Therapeutics, Inc. | Series A | - |
1/2018 | Invicta Medical | Series B | 0 |
7/2016 | Invicta Medical | Series A | 0 |
10/2017 | 3T Biosciences | Seed Round | 12M |
1/2020 | Advano | Series A | 18.5M |
7/2017 | Angiex | Series A | 3M |
5/2018 | Terminal | Series A | 10M |
11/2021 | Mynaric | Post-IPO Equity | 0 |
12/2020 | Rational Vaccines | Series A | 10M |
4/2021 | Angiex | Series B | 25M |
7/2022 | Inflection Points | Seed Round | 0 |
8/2020 | Ready | Seed Round | 1.2M |
6/2021 | Ex-human | Pre Seed Round | 550k |
7/2022 | Inflection Points | Seed Round | 0 |
2/2022 | Regent | Venture Round | 0 |
11/2021 | Mynaric | Post-IPO Equity | 0 |
6/2021 | Ex-human | Pre Seed Round | 0 |
5/2021 | Bullish Global | Venture Round | 0 |
4/2021 | Angiex | Series B | 0 |
3/2021 | ATAI Life Sciences | Series D | 0 |
12/2020 | Rational Vaccines | Series A | 0 |
11/2020 | ATAI Life Sciences | Series C | 0 |
8/2020 | Ready | Seed Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|